2023-05-18T08:28:06-04:00Sense Neuro Diagnostics receives $2.43 Million from US Military to advance technology to diagnose and monitor traumatic brain injury (TBI) in a field environment2023-05-18T08:28:06-04:00August 2, 2021|
2023-05-18T08:28:07-04:00PROOF Research awarded contract for future weapon systems development2023-05-18T08:28:07-04:00July 15, 2021|
2023-05-18T08:28:07-04:00Kane Biotech announces two key milestones as DispersinB® wound care project advances towards human clinical trials2023-05-18T08:28:07-04:00July 14, 2021|
2023-05-18T08:28:07-04:00Ischemix, Inc. receives US Department of Defense funding of $2.9 million to conduct Phase 1 study of CMX-2043, a novel compound for the treatment of acute TBI2023-05-18T08:28:07-04:00July 7, 2021|